NCT03903536

Brief Summary

The primary aim of the current study is to evaluate and compare 6-month complication rates after thrombectomy and local excision treatments. The investigators aim to compare thrombectomy and local excision treatments in many different aspects:

  • The investigators will follow these patients for 6 months by scheduling follow-up visits (or by phone if the patient cannot attend) 4 times during this period (1st week, 1st month, 3rd month, 6th month).
  • The investigators will examine bleeding, pain, anal stricture/stenosis, infection, time until return to normal daily activity, relapse and incontinence after treatment
  • To assess quality of life outcomes, the investigators use the 36-Item Short Form Health Survey (SF-36). These measures rely upon patient self-reporting and are utilized for routine monitoring and assessment of care outcomes in patients.
  • The investigators will use the Wexner incontinence score for assessment of incontinence. In each hospital, medical students, residents and surgeons can be involved in the study. In the following 6-month period, all collaborators will be collecting the data of the patients who have been operated for external hemorrhoids via the thrombectomy or local excision procedures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
96

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2020

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 1, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 4, 2019

Completed
1.4 years until next milestone

Study Start

First participant enrolled

September 1, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2021

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2022

Completed
Last Updated

July 18, 2023

Status Verified

July 1, 2023

Enrollment Period

1 year

First QC Date

April 1, 2019

Last Update Submit

July 17, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • 6-month complication rate

    * The investigators will follow these patients for 6 months by scheduling follow-up visits (or by phone if the patient cannot attend) 4 times during this period (1st week, 1st month, 3rd month, 6th month). * The investigators will examine anal bleeding(exist or not), pain(exist or not), anal stricture/stenosis(exist or not, its severity), infection(exist or not), time until return to normal daily activity, relapse and incontinence after treatment. * The investigators will use the Wexner incontinence score for assessment of incontinence. * The investigators will measure the internal diameter of anal canal for the assessment of anal stenosis and its severity. When the internal diameter of anal canal is less than 0.5 cm, it is severe stenosis and when the diameter is 0.5-1 cm stenosis is moderate and 1-1.5 cm diameter is known as mild stenosis.

    6 months from operation

  • 6-month quality of life outcomes

    Quality of life outcomes within 6 months of surgical procedure. To assess quality of life outcomes, the investigators use the 36-Item Short Form Health Survey (SF-36). The SF-36 has eight scaled scores; the scores are weighted sums of the questions in each section. Scores range from 0 - 100. Lower scores = more disability, higher scores = less disability. Sections: * Vitality * Physical functioning * Bodily pain * General health perceptions * Physical role functioning * Emotional role functioning * Social role functioning * Mental health

    6 months from operation

Study Arms (2)

Thrombectomy

Patients with thrombosed external hemorrhoids undergoing thrombectomy

Procedure: Thrombectomy

Local excision/ Hemorrhoidectomy

Patients with thrombosed external hemorrhoids undergoing local excision/ hemorrhoidectomy

Procedure: Hemorrhoidectomy

Interventions

ThrombectomyPROCEDURE

A small procedure where surgeons make a cut in the hemorrhoid and drain the blood.

Thrombectomy

A surgery to remove the hemorrhoid, including the blood vessels and clot.

Local excision/ Hemorrhoidectomy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who apply (or are referred) to general surgery departments and are diagnosis with thrombosed external hemorrhoids will be included in the study.

You may qualify if:

  • Patients who are diagnosis with thrombosed external hemorrhoids.
  • Providing a written informed consent form for the surgeries and for participation in the study
  • Patients aged 18 years and over should be included

You may not qualify if:

  • Patients younger than 18 years of age,
  • Pregnancy
  • Patients who have a history of cancer or inflammatory bowel disease(IBD)
  • Patients who have a history of anorectal fistula
  • Patients with metabolic disorders
  • Patients with alcohol or substance addiction
  • Patients who refuse to participate in the study and do not provide informed consent
  • Patients who, at any stage of the study, indicate that they want to leave the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Gazi University

Ankara, 06560, Turkey (Türkiye)

Location

Yildirim Beyazit University Yenimahalle Training and Research Hospital

Ankara, 06560, Turkey (Türkiye)

Location

MeSH Terms

Interventions

ThrombectomyHemorrhoidectomy

Intervention Hierarchy (Ancestors)

Vascular Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, OperativeDigestive System Surgical Procedures

Study Officials

  • Sezai Leventoglu, Professor

    Gazi University Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 1, 2019

First Posted

April 4, 2019

Study Start

September 1, 2020

Primary Completion

September 1, 2021

Study Completion

June 1, 2022

Last Updated

July 18, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will share

Derived anonymised data at the patient-level may be able to be made available for sharing

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Following publication of the main results

Locations